The Effects of Lipid Lowering on Diabetic Retinopathy
References (20)
Abnormal lipoprotein metabolism in non-insulin-dependent diabetes mellitus
Am. J. Med.
(1987)- et al.
Long-term treatment of hypercholesterolemic non-insulin dependent diabetics (NIDDM) with pravastatin (CS-514)
Atherosclerosis
(1989) - et al.
The Wisconsin Epidemiologic Study of Diabetic Retinopathy VII. Diabetic nonproliferative retinal lesions
Ophthalmology
(1987) - et al.
The cardiovascular risk profile of adolescents with insulin-dependent diabetes mellitus
Diabetes Care
(1985) - et al.
Hyperlipidemia and atherosclerosis. Chronic hyperlipidemia initiates and maintains lesions by endothelial cell desquamation and lipid accumulation
Science
(1976) - et al.
Injury to human endothelial cells in culture induced by low density lipoproteins
Scand. J. Clin. Lab. Invest.
(1979) - et al.
Exudative diabetic retinopathy. Spontaneous changes and effects of a corn oil diet
Br. J. Ophthalmol.
(1963) - et al.
A double-blind controlled trial of clofibrate in the treatment of diabetic retinopathy
Diabetes
(1969) - et al.
A three-year trial of atromid therapy in exudative diabetic retinopathy
Diabetes
(1968) - et al.
Lovastatin for lowering cholesterol in non-insulin-dependent diabetes mellitus
N. Engl. J. Med.
(1988)
There are more references available in the full text version of this article.
Cited by (132)
HbA1C, proliferative and non-proliferative retinopathy in diabetic patients
2023, Medicina Clinica PracticaLipids, atherosclerosis, and microvascular disease: Translating basic science into pharmacotherapeutics
2023, Cardiovascular Endocrinology and Metabolism: Theory and Practice of Cardiometabolic MedicineEffect of Modifiable Risk Factors on the Incidence and Progression of Diabetic Retinopathy
2018, Current Management of Diabetic RetinopathyStatins in ophthalmology
2019, Survey of OphthalmologyCitation Excerpt :All 6 patients had improvement in HEs, and four had improvement in microaneurysms that correlated to their lowered total cholesterol and LDL levels. VA improved in one patient and remained unchanged in the rest.64 The first double-blind randomized trial enrolled 50 patients with hypercholesterolemia and DR (type 1 and 2) who were randomized to 20 mg of simvastatin daily or placebo and followed up for 6 months.
Impact of Dyslipidemia Medications on the Prevalence of Diabetic Retinopathy Among a Large US Cohort
2023, Ophthalmic Surgery Lasers and Imaging Retina
This study was supported in part by grants from Bristol-Meyers Squibb, the Louis Calder Foundation, and the Starr Foundation.
Reprint requests to Bruce R. Gordon, M.D., Rogosin Institute, 505 E. 70th St., New York, NY 10021.
Copyright © 1991 Elsevier Inc. All rights reserved.